Health Care·Health Care Equipment·$12.9B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.04 | N/A | +64.60% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.04 | N/A | +64.60% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management acknowledged the difficulties faced in the current market environment. They remain focused on long-term strategies but did not provide specific guidance for the upcoming quarters.
Management highlighted ongoing challenges in the market.
They emphasized a focus on long-term growth despite current setbacks.
There was no specific guidance provided for future quarters.
Penumbra's earnings report shows a mixed picture with a narrower-than-expected loss per share, but the lack of revenue details and guidance has raised concerns. The stock reacted negatively, dropping 4.79%, likely due to uncertainties about future performance and management's cautious tone during the earnings call. Investors may be wary as the company navigates current market challenges without clear direction.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
MONOLITHIC PWR SYS I
Oct 31, 2016